|
|
|
40
|
3653CT
|
NASONEX 50MCG NASAL SP (MSD/STO) MOMETASONE
|
MOMETASONE
|
NASONEX
|
120 DOSES
|
C
|
17.07
|
17.07
|
NASAL SPRAY
|
0
|
BOTT
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
3653CT
|
NASONEX 50MCG NASAL SP (MSD) MOMETA (C)
|
MOMETASONE
|
NASONEX
|
120 DOSES
|
C
|
17.26
|
17.2614
|
BOTT
|
1
|
BOTT
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
3653CT
|
NASONEX 50MCG NASAL SP (MSD) MOMET (C)
|
MOMETASONE
|
NASONEX
|
120 DOSES
|
C
|
17.26
|
17.26
|
BOTT
|
1
|
BOTT
|
MSD
|
MERCK SHARP & DOHME (I.A.) CORP
|
STO
|
BRYDEN STOKES LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
2028-03-31
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
3653CW
|
APO-MOMETASONE 50MCG NASAL SP (APO)
|
MOMETASONE
|
APO-MOMETASONE
|
140 DOSES
|
A
|
7.83
|
7.8288
|
BOTT
|
1
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
INHALATION
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
3653DG
|
NEOTISON 27.5MCG NASAL SP (INC) FLUTICASONE
|
FLUTICASONE
|
NEOTISON
|
120 DOSES
|
A
|
8.97
|
8.97
|
BOTT
|
1
|
BOTT
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5202
|
ANTIALLERGIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
NASAL
|
6
|
ANTIALLERGIC AGENTS
|
|
|
|
|
42
|
3653DK
|
FLUBREATH 50MCG NASAL SP (JLP) FLUTICASONE
|
FLUTICASONE
|
FLUBREATH
|
120 DOSES
|
A
|
4.57
|
4.57
|
BOTT
|
1
|
CNN
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5202
|
ANTIALLERGIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
NASAL
|
6
|
ANTIALLERGIC AGENTS
|
|
|
|
|
42
|
3653DL
|
NAZERELIEF 50MCG NASAL SP (JLP) MOMETASONE
|
MOMETASONE
|
NAZERELIEF
|
100 DOSES
|
A
|
2.20
|
2.20
|
BOTT
|
1
|
BOTT
|
JLP
|
JOHN LEE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5202
|
ANTIALLERGIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
INHALATION
|
6
|
ANTIALLERGIC AGENTS
|
|
|
|
|
40
|
3653P
|
FLIXONASE 50MCG NASAL SP (GSK/COL) FLUTICASON
|
FLUTICASONE
|
FLIXONASE
|
120 DOSES
|
A
|
12.91
|
12.91
|
NASAL SPRAY
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
3653P
|
FLIXONASE 50MCG NASAL SP (GSK) FLUTICASO
|
FLUTICASONE
|
FLIXONASE
|
120 DOSES
|
A
|
13.67
|
13.6732
|
BOTT
|
1
|
BOTT
|
GSK
|
GLAXOSMITHKLINE
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2024-07-25
|
|
NASAL
|
6
|
EENT ANTI-INFLAMMATORY AGENTS
|
2024-06-13
|
|
|
|
40
|
3653T
|
NASACORT AQ 55MCG NASAL SP (SFA/COL) TRIAMCIN
|
TRIAMCINOLONE
|
NASACORT AQ
|
120 DOSES
|
A
|
12.23
|
12.23
|
NASAL SPRAY
|
1
|
BOTT
|
SFA
|
SANOFI AVENTIS
|
COL
|
COLLINS LTD
|
|
5208
|
EENT ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
NASAL
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
36551
|
BRIXIA 0.05% EYE DR (LPO/COL) AZELASTINE
|
AZELASTINE
|
BRIXIA
|
6ML
|
A
|
6.25
|
6.25
|
EYE DROP
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5202
|
ANTIALLERGIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
36551
|
BRIXIA 0.05% EYE DR (LPO) AZELASTINE
|
AZELASTINE
|
BRIXIA
|
6ML
|
A
|
6.88
|
6.8774
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5202
|
ANTIALLERGIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIALLERGIC AGENTS
|
|
|
|
|
42
|
36551
|
BRIXIA 0.05% EYE DR (LPO) AZELASTINE
|
AZELASTINE
|
BRIXIA
|
6ML
|
A
|
19.03
|
19.03
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
AVENTA BARBADOS
|
|
5202
|
ANTIALLERGIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
OPHTHALMIC
|
6
|
ANTIALLERGIC AGENTS
|
|
|
|
|
40
|
36613
|
LIPOFUNDIN 20% INJ (BRA/COL) SOYA BEAN OIL
|
SOYA BEAN OIL
|
LIPOFUNDIN
|
500ML
|
BQ
|
34.39
|
34.39
|
INJECTION
|
0
|
BOTT
|
BRA
|
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE
|
COL
|
COLLINS LTD
|
|
4020
|
CALORIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ELECTROLYTIC, CALORIC, AND WATER BALANCE
|
|
|
|
|
41
|
36613
|
LIPOFUNDIN 20% INJ (BRA) SOYA BEAN OIL
|
SOYA BEAN OIL
|
LIPOFUNDIN
|
500ML
|
BQ
|
41.26
|
41.2642
|
BOTT
|
0
|
BOTT
|
BRA
|
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE
|
COL
|
COLLINS LTD
|
|
4020
|
CALORIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
CALORIC AGENTS
|
|
|
|
|
42
|
36613
|
LIPOFUNDIN 20% INJ (BRA) SOYA BEAN OIL
|
SOYA BEAN OIL
|
LIPOFUNDIN
|
500ML
|
BQ
|
65.24
|
65.24
|
BOTT
|
0
|
BOTT
|
BRA
|
B. BRAUN MELSUNGEN AG CARL-BRAUN-STRABE
|
COL
|
AVENTA BARBADOS
|
|
4020
|
CALORIC AGENTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
CALORIC AGENTS
|
|
|
|
|
40
|
3681G
|
NALOXONE 0.4MG/ML INJ (RTM/PHA)
|
NALOXONE
|
NALOXONE
|
10X1ML
|
BQ
|
49.25
|
4.925
|
INJECTION
|
|
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2810
|
OPIATE ANTAGONISTS
|
2022-04-01
|
2024-03-31
|
Add to Contract as Cat B
|
IV
|
|
OPIATE ANTAGONISTS
|
2023-02-22
|
|
|
|
41
|
3681G
|
NALOXONE 0.4MG/ML INJ (RTM) (B)
|
NALOXONE
|
NALOXONE
|
10X1ML
|
B
|
57.3
|
5.7302
|
AMP
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2810
|
OPIATE ANTAGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE ANTAGONISTS
|
|
|
|
|
42
|
3681G
|
NALOXONE 0.4MG/ML INJ (RTM)
|
NALOXONE
|
NALOXONE
|
10X1ML
|
B
|
40.77
|
4.08
|
AMPG
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
2810
|
OPIATE ANTAGONISTS
|
2026-04-01
|
2028-03-31
|
|
IV
|
0
|
OPIATE ANTAGONISTS
|
|
|
|
|
41
|
3681Q
|
N-XONE 0.4MG/ML INJ (VEV) NALOXONE (B)
|
NALOXONE
|
N-XONE
|
10X1ML
|
B
|
47.3
|
4.7299
|
AMP
|
0
|
BOX
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
2810
|
OPIATE ANTAGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE ANTAGONISTS
|
|
